100 related articles for article (PubMed ID: 1687521)
1. Monoclonal antibodies in breast and ovarian cancer. Proceedings of the British Association for Cancer Research Workshop, Oxford, 17-19 March, 1991.
Dis Markers; 1991; 9(3-4):125-238. PubMed ID: 1687521
[No Abstract] [Full Text] [Related]
2. Report of BACR workshop on monoclonal antibodies in breast and ovarian cancer, Brasenose College, Oxford March 17-19th 1991.
Leonard RC; Fisken J; Roulston JE
Br J Cancer; 1991 Oct; 64(4):796-7. PubMed ID: 1911231
[No Abstract] [Full Text] [Related]
3. [Monoclonal antibodies in gynecologic oncology. I. Diagnostic aspects].
Sesti F; Farnè C; Piccione E
G Ital Oncol; 1987; 7(2-3):83-9. PubMed ID: 3333369
[No Abstract] [Full Text] [Related]
4. Carcinoma of the breast and of the ovary as a model for the application of monoclonal antibodies to diagnostic pathology.
Rilke F; Colnaghi MI; Ménard S; Tagliabue E; Mariani-Costantini R; Della Torre G
Monogr Pathol; 1986; (27):206-24. PubMed ID: 3020396
[No Abstract] [Full Text] [Related]
5. Monoclonal antibodies to detect markers specific for tumors.
Klavins JV
Ann Clin Lab Sci; 1987; 17(4):221-5. PubMed ID: 3619397
[TBL] [Abstract][Full Text] [Related]
6. [Use of radioimmunoanalysis of tumor markers in the diagnosis of carcinoma of the breast, ovary and intestines].
Kausitz J
Bratisl Lek Listy; 1988 Aug; 89(8):563-76. PubMed ID: 3179762
[No Abstract] [Full Text] [Related]
7. The emerging role of monoclonal antibodies in the clinical management of epithelial ovarian carcinoma.
Bast RC; Knapp RC
Important Adv Oncol; 1987; ():39-53. PubMed ID: 3331386
[No Abstract] [Full Text] [Related]
8. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
9. Immunodiagnosis of ovarian tumors.
Jacobs I; Bast RC
Immunol Ser; 1990; 53():323-38. PubMed ID: 2100566
[No Abstract] [Full Text] [Related]
10. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
Sevelda P; Salzer H; Dittrich C; Spona J
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):769-73. PubMed ID: 3865860
[TBL] [Abstract][Full Text] [Related]
12. A menu of markers for breast cancer.
Check WA
CAP Today; 1994 Jul; 8(7):1, 20, 24-5 passim. PubMed ID: 10150193
[No Abstract] [Full Text] [Related]
13. Validation and comparison of anti-αvβ3 and anti-αvβ5 rabbit monoclonal versus murine monoclonal antibodies in four different tumor entities.
Böger C; Kalthoff H; Goodman SL; Röcken C
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):553-60. PubMed ID: 23455183
[TBL] [Abstract][Full Text] [Related]
14. Molecular markers of breast and ovarian cancer.
Steel CM
Dis Markers; 1991; 9(3-4):213-23. PubMed ID: 1813211
[No Abstract] [Full Text] [Related]
15. BRCA1: genetic testing and hereditary breast and ovarian cancer.
Ross DW
Arch Pathol Lab Med; 1997 Jul; 121(7):754-5. PubMed ID: 9240915
[No Abstract] [Full Text] [Related]
16. Distinguishing breast carcinoma from Müllerian serous carcinoma with mammaglobin and mesothelin.
Kanner WA; Galgano MT; Stoler MH; Mills SE; Atkins KA
Int J Gynecol Pathol; 2008 Oct; 27(4):491-5. PubMed ID: 18753974
[TBL] [Abstract][Full Text] [Related]
17. [HER2 testing in breast cancer].
Yoshimura K
Nihon Rinsho; 2007 Jun; 65 Suppl 6():275-80. PubMed ID: 17682167
[No Abstract] [Full Text] [Related]
18. [Genital metastases from breast cancer: study of 3 cases and literature review].
Zoukar O; Haddad A; Daldoul A; Zaied S; Salem AB; Zouari I; Faleh R
Pan Afr Med J; 2018; 30():7. PubMed ID: 30123410
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunodiagnosis of ovarian cancer using 123I-labelled, tumor-associated monoclonal antibodies.
Epenetos AA; Shepherd J; Britton KE; Hawkins L; Nimmon CC; Taylor-Papadimitriou J; Durbin H; Malpas JS; Mather S; Granowska M
Cancer Detect Prev; 1984; 7(1):45-9. PubMed ID: 6367983
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.
Ugrinska A; Bombardieri E; Stokkel MP; Crippa F; Pauwels EK
Q J Nucl Med; 2002 Jun; 46(2):88-104. PubMed ID: 12114872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
